Juvenile Diabetes Research Foundation (JDRF): Exploratory Clinical Trials to Prevent Progression of Diabetic Nephropathy- LOI

LOIs are sought from investigators with approved or investigational drug candidates to validate mechanism of action and/or efficacy in preventing progression or reversal of diabetic nephropathy in T1D. JDRF is particularly interested in targeting patients with disease no more severe than CKD3 based on NKF definitions, as well as, trials that use novel approaches to stratify entry population based on estimated risk of progression during the trial. Under exceptional circumstances, proposals that also include preclinical studies may be considered if needed to obtain regulatory approval to move forward with the proposed clinical trial. Funding: up to $1 million/yr for up to 3 yrs.
http://jdrf.org/grant-center/grant-opportunities-and-deadlines/